FEMY is trading at $4.18 (5.6%) up in after-hours trading, rebounding from recent weakness and continuing its pattern of sharp moves typical for low-float biotech stocks.
- There is no fresh company-specific news or earnings today to account for the price action.
- Recent commentary points to speculative trading, message-board buzz, and filing-related interest as key drivers rather than fundamental changes.